TY - JOUR
T1 - Partner Disclosure of PrEP Use and Undetectable Viral Load on Geosocial Networking Apps
T2 - Frequency of Disclosure and Decisions about Condomless Sex
AU - Newcomb, Michael E.
AU - Mongrella, Melissa C.
AU - Weis, Benjamin
AU - McMillen, Samuel J.
AU - Mustanski, Brian
N1 - Funding Information:
Data for this study were gathered in concert with online recruitment efforts for the Keep It Up! randomized clinical trial funded by the National Institute on Drug Abuse (R01DA035145, PI: B.M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors give special thanks to Krystal Madkins and Craig Sineath for managing the advertisement campaign and to Katie Andrews for survey programing and data management.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Background: Recent advances in biomedical prevention strategies, including pre-exposure prophylaxis (PrEP) and achieving an undetectable viral load (UVL) among HIV-infected persons, show promise in curbing the rising incidence of HIV among men who have sex with men (MSM) in the United States. This mixed-methods study aimed to investigate the frequency with which MSM encounter potential sex partners on geosocial networking apps who disclose biomedical prevention use, and how MSM make decisions about condom use after these disclosures. Method: Participants were recruited through advertisements placed on a large geosocial networking app for MSM. A total of 668 and 727 participants, respectively, responded to questionnaires assessing partner disclosure of PrEP use and UVL. Each questionnaire included an open-ended item assessing reasons for condomless anal sex (CAS) with partners using biomedical prevention. Results: Across both surveys, most respondents encountered potential sex partners who disclosed PrEP use or UVL, and the majority of those who met up with these partners engaged in CAS at least once. Qualitative analyses found that most participants who reported CAS did so after making a calculated risk about HIV transmission. We also describe a novel risk reduction strategy, "biomed-matching," or having CAS only when both individuals use PrEP or have UVL. We report serostatus differences in both quantitative and qualitative findings. Conclusions: Disclosure of PrEP use and UVL is not uncommon among MSM. Many MSM make accurate appraisals of the risks of CAS with biomedical prevention, and mobile apps may aid with disclosing biomedical prevention use.
AB - Background: Recent advances in biomedical prevention strategies, including pre-exposure prophylaxis (PrEP) and achieving an undetectable viral load (UVL) among HIV-infected persons, show promise in curbing the rising incidence of HIV among men who have sex with men (MSM) in the United States. This mixed-methods study aimed to investigate the frequency with which MSM encounter potential sex partners on geosocial networking apps who disclose biomedical prevention use, and how MSM make decisions about condom use after these disclosures. Method: Participants were recruited through advertisements placed on a large geosocial networking app for MSM. A total of 668 and 727 participants, respectively, responded to questionnaires assessing partner disclosure of PrEP use and UVL. Each questionnaire included an open-ended item assessing reasons for condomless anal sex (CAS) with partners using biomedical prevention. Results: Across both surveys, most respondents encountered potential sex partners who disclosed PrEP use or UVL, and the majority of those who met up with these partners engaged in CAS at least once. Qualitative analyses found that most participants who reported CAS did so after making a calculated risk about HIV transmission. We also describe a novel risk reduction strategy, "biomed-matching," or having CAS only when both individuals use PrEP or have UVL. We report serostatus differences in both quantitative and qualitative findings. Conclusions: Disclosure of PrEP use and UVL is not uncommon among MSM. Many MSM make accurate appraisals of the risks of CAS with biomedical prevention, and mobile apps may aid with disclosing biomedical prevention use.
KW - HIV/AIDS
KW - biomedical prevention
KW - men who have sex with men
KW - pre-exposure prophylaxis
KW - viral suppression
UR - http://www.scopus.com/inward/record.url?scp=84955606201&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955606201&partnerID=8YFLogxK
U2 - 10.1097/QAI.0000000000000819
DO - 10.1097/QAI.0000000000000819
M3 - Article
C2 - 26761520
AN - SCOPUS:84955606201
VL - 71
SP - 200
EP - 206
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
SN - 1525-4135
IS - 2
ER -